Date	Period	Revenue/Estimate	Earnings Call
Jan 31, 2025	2024/Q4	-- / 12.563B	--
Oct 29, 2024	2024/Q3	-- / 12.650B	--
Jul 18, 2024	2024/Q2	12.512B / 12.319B	--
Apr 23, 2024	2024/Q1	11.829B / 11.498B	--
Jan 31, 2024	2023/Q4	11.423B / 11.773B	--

DatePeriodRevenue/EstimateEarnings Call

Jan 31, 20252024/Q4-- / 12.563B--

Oct 29, 20242024/Q3-- / 12.650B--

Jul 18, 20242024/Q212.512B / 12.319B--

Apr 23, 20242024/Q111.829B / 11.498B--

Jan 31, 20242023/Q411.423B / 11.773B--

Unlock Free Earnings Estimates

Open Account

6-K: Explanatory Note

Sep 18 16:42 ET

6-K: Novartis Second Quarter and Half Year 2024 Condensed Interim Financial Report – Supplementary Data

Jul 18 06:11 ET

6-K: Financial Report Q1 2024

Apr 23 06:09 ET

Novartis AG | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 31 07:46 ET

Updated: Sep 30, 2024

Hold

No Data

Overall

No Data

NVS Novartis AG

Novartis AG Key Stats